Mallinckrodt
 

about

Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company’s Specialty Brands reportable segment’s areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics.

Sheila Talafous
Director, Advocacy Relations
Mallinckrodt Pharmaceuticals
1425 Route 206
Bedminster, NJ 07921
908-238-6351 T
908-581-5123 M
sheila.talafous@mnk.com
www.mnk.com


Information and resources presented on this page were provided by our DuchenneXchange Industry sponsors.